Synthesis of unsymmetrical monocarbonyl curcumin analogues with potent inhibition on prostaglandin E2 production in LPS-induced murine and human macrophages cell lines

Article abstract of DOI:10.1016/j.bmcl.2016.03.092

The syntheses and bioactivities of symmetrical curcumin and its analogues have been the subject of interest by many medicinal chemists and pharmacologists over the years. To improve our understanding, we have synthesized a series of unsymmetrical monocarbonyl curcumin analogues and evaluated their effects on prostaglandin E₂ production in lipopolysaccharide-induced RAW264.7 and U937 cells. Initially, compounds 8b and 8c exhibited strong inhibition on the production of PGE₂ in both LPS-stimulated RAW264.7 (8b, IC₅₀ = 12.01 M and 8c, IC₅₀ = 4.86 μM) and U937 (8b, IC₅₀ = 3.44 μM and 8c, IC₅₀ = 1.65 μM) cells. Placing vanillin at position Ar₂ further improved the potency when both compounds 15a and 15b significantly lowered the PGE₂ secretion level (RAW264.7: 15a, IC₅₀ = 0.78 μM and 15b, IC₅₀ = 1.9 μM while U937: 15a, IC₅₀ = 0.95 μM and 15b, IC₅₀ = 0.92 μM). Further experiment showed that compounds 8b, 8c, 15a and 15b did not target the activity of downstream inflammatory COX-2 mediator. Finally, docking simulation on protein targets COX-2, IKK-β, ERK, JNK2, p38α and p38β were performed using the conformation of 15a determined by single-crystal XRD.